N.J. Admin. Code § 13:39-7.10 - Prescriptions transmitted by facsimile
(a) A pharmacist
may accept for dispensing a facsimile prescription, consistent with the
requirements of this section. For purposes of this section, "facsimile
prescription" means a prescription which is transmitted by a device which sends
an exact image to the receiver.
(b)
A pharmacist shall not fill a facsimile prescription transmitted by anyone
other than a practitioner authorized to prescribe medications pursuant to
N.J.S.A.
45:14-40, or the prescribing practitioner's
authorized agent.
(c) The facsimile
machine used to receive prescriptions shall be located within the pharmacy
prescription area.
(d) A facsimile
prescription shall contain all information required to be included on a written
prescription pursuant to New Jersey State Board of Medical Examiners rule
N.J.A.C.
13:35-7.2(d), except that an
NJPB shall not be required for the prescription.
(e) The facsimile transmission of the
prescription shall contain the following:
1.
The identification number of the facsimile machine which is used to transmit
the prescription;
2. The date and
time of the prescription transmission;
3. The name, address, telephone number and
facsimile number of the pharmacy; and
4. If an authorized agent transmits the
facsimile prescription, the full name and title of the transmitting
agent.
(f) A pharmacist
shall seek verbal verification of a facsimile prescription from the prescribing
practitioner whenever the pharmacist has reason to question the authenticity,
accuracy or appropriateness of the prescription. A pharmacist may accept verbal
verification regarding the authenticity or legibility of a facsimile
prescription from a prescribing practitioner's authorized agent. A pharmacist
shall not fill a facsimile prescription where there is a question regarding
authenticity, accuracy or appropriateness if such verification is not
provided.
(g) A pharmacist shall
retain a printed copy of a facsimile prescription, or an electronic
reproduction of the facsimile prescription that is readily retrievable and
printable, for a minimum of five years. The printed copy shall be of non-fading
legibility.
(h) A pharmacist may
fill a prescription for a Schedule II controlled substance transmitted by
facsimile provided that the original signed prescription is presented to the
pharmacist prior to the dispensing of the controlled substance, except as
provided in (h)1, 2 and 3 below.
1. A
prescription for a Schedule II narcotic substance prescribed for pain
management to be compounded for the direct administration to a patient by
parenteral, intravenous, intramuscular, subcutaneous or intraspinal infusion
may be transmitted by the practitioner or the practitioner's agent to the
dispensing pharmacy by facsimile. The facsimile shall serve as the original
written prescription and shall be maintained pursuant to the requirements of
(g) above.
2. A prescription for a
Schedule II substance prescribed for pain management for a resident of a
long-term care facility may be transmitted by the practitioner or the
practitioner's agent to the dispensing pharmacy by facsimile. The facsimile
shall serve as the original written prescription and shall be maintained
pursuant to the requirements of (g) above.
3. A prescription for a Schedule II narcotic
substance prescribed for pain management for a patient receiving services from
a hospice certified by Medicare under Title XVIII or licensed by the State may
be transmitted by the practitioner or the practitioner's agent to the
dispensing pharmacy by facsimile. The practitioner or the practitioner's agent
shall note on the facsimile prescription that the patient is a hospice patient.
The facsimile shall serve as the original written prescription and shall be
maintained pursuant to the requirements of (g) above.
(i) A pharmacist may fill a prescription for
a Schedule III, IV or V controlled substance transmitted by facsimile
consistent with the requirements of this section. The facsimile prescription
shall serve as the original written prescription.
(j) A pharmacist shall not enter into any
agreement with a prescribing practitioner that requires that facsimile
prescriptions be transmitted to a particular pharmacy or in any way denies a
patient the right to have his or her prescription transmitted by facsimile to a
pharmacy of the patient's choice.
(k) Nothing in this section shall be
construed to preclude the facsimile transfer of information between pharmacies
for purposes of transferring prescriptions pursuant to
N.J.A.C.
13:39-7.8.
(
l) A pharmacist shall not use a technological
device in order to circumvent his or her responsibilities with regard to
verifying the validity of prescriptions or in order to circumvent other
standards of pharmacy practice.
Notes
See: 34 N.J.R. 3064(a), 35 N.J.R. 4290(a).
Administrative correction.
See: 35 N.J.R. 4724(a).
Recodified from N.J.A.C. 13:39-5.8A by R.2005 d.25, effective
See: 36 N.J.R. 3345(a), 37 N.J.R. 295(a).
Former N.J.A.C. 13:39-7.10, Return of prescription medication, recodified to N.J.A.C. 13:39-7.16.
Amended by R.2010 d.090, effective
See: 42 N.J.R. 132(a), 42 N.J.R. 1221(a).
In (b), updated the N.J.S.A. reference; in (g), deleted "pursuant to N.J.S.A. 45:14-15" following "five years"; and added (k) and ( l).
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.